NR 565 Final Exam: Advanced Pharmacology
Fundamentals V2 Updated and Latest Questions and
Correct Answers with Rationale
1. Which pharmacokinetic process is primarily affected by the ‘first-pass effect’ during oral
administration?
A. Distribution
B. Excretion
C. Metabolism
D. Absorption
Ans: C
Rationale: The first-pass effect occurs when a drug is metabolized in the liver before reaching systemic
circulation. This process significantly reduces the bioavailability of many orally administered
medications. Most drugs absorbed from the gastrointestinal tract pass through the portal vein to the
liver. This explains why some drugs must be given via sublingual or IV routes to be effective. Clinicians
must consider this effect when determining appropriate dosages for their patients. Effective management
requires an understanding of how hepatic enzymes interact with specific pharmaceutical compounds.
,2. Which of the following describes an ‘agonist’ in terms of pharmacodynamics?
A. A drug that blocks the action of a neurotransmitter
B. A drug that binds to a receptor and activates it
C. A drug that has no affinity for receptors
D. A drug that decreases the sensitivity of a receptor
Ans: B
Rationale: An agonist is a chemical that binds to a receptor and activates the receptor to produce a
biological response. This activation mimics the effects of endogenous ligands within the human body. In
contrast, an antagonist binds to the receptor but does not activate it, effectively blocking other signals.
The strength of the response is often proportional to the number of receptors occupied. Advanced
pharmacology focuses on the affinity and efficacy of these drugs at target sites. Understanding these
relationships is crucial for predicting therapeutic outcomes and potential side effects.
3. What is the primary reason for dosage adjustments in geriatric patients?
A. Increased gastric acidity
B. Rapid liver metabolism
C. Increased total body water
D. Decreased renal clearance
Ans: D
Rationale: As patients age, there is a natural decline in renal function and glomerular filtration rate. This
reduction leads to the slower excretion of drugs that are primarily cleared by the kidneys. If dosages are
,not adjusted, geriatric patients face a significantly higher risk of drug toxicity. Prescribers often use the
Cockcroft-Gault equation to estimate creatinine clearance in this population. It is also important to note
that physiological changes like increased body fat can alter distribution. Careful monitoring is the
cornerstone of safe prescribing for elderly individuals with multiple comorbidities.
4. Which drug class is most commonly associated with a dry, non-productive cough as a side
effect?
A. ACE inhibitors
C. Beta-blockers
B. Calcium channel blockers
D. Statins
Ans: A
Rationale: ACE inhibitors prevent the conversion of angiotensin I to angiotensin II to lower blood
pressure. A common side effect is a persistent dry cough caused by the accumulation of bradykinin in the
lungs. This cough can be bothersome enough to lead to patient non-compliance with the therapy. If the
cough persists, many providers switch the patient to an Angiotensin Receptor Blocker (ARB). ARBs
provide similar cardiovascular benefits without interfering with the breakdown of inflammatory
mediators. Recognizing this class-specific adverse effect is a key competency for advanced practice
nurses.
, 5. When prescribing for a pregnant patient, which FDA category previously indicated that
human fetal risk has been demonstrated?
A. Category A
B. Category B
C. Category X
D. Category C
Ans: C
Rationale: Category X was used for drugs where the risks of use in pregnant women clearly outweighed
any possible benefits. Studies in animals or humans showed evidence of fetal abnormalities or positive
evidence of fetal risk. Although the FDA has moved toward the Pregnancy and Lactation Labeling Rule
(PLLR), these categories are still widely referenced. Prescribers must evaluate the risk-to-benefit ratio for
every medication used during gestation. Safety is paramount because many substances cross the
placental barrier and affect fetal development. Accurate documentation and patient education are
required for all prescriptions given to expectant mothers.
Fundamentals V2 Updated and Latest Questions and
Correct Answers with Rationale
1. Which pharmacokinetic process is primarily affected by the ‘first-pass effect’ during oral
administration?
A. Distribution
B. Excretion
C. Metabolism
D. Absorption
Ans: C
Rationale: The first-pass effect occurs when a drug is metabolized in the liver before reaching systemic
circulation. This process significantly reduces the bioavailability of many orally administered
medications. Most drugs absorbed from the gastrointestinal tract pass through the portal vein to the
liver. This explains why some drugs must be given via sublingual or IV routes to be effective. Clinicians
must consider this effect when determining appropriate dosages for their patients. Effective management
requires an understanding of how hepatic enzymes interact with specific pharmaceutical compounds.
,2. Which of the following describes an ‘agonist’ in terms of pharmacodynamics?
A. A drug that blocks the action of a neurotransmitter
B. A drug that binds to a receptor and activates it
C. A drug that has no affinity for receptors
D. A drug that decreases the sensitivity of a receptor
Ans: B
Rationale: An agonist is a chemical that binds to a receptor and activates the receptor to produce a
biological response. This activation mimics the effects of endogenous ligands within the human body. In
contrast, an antagonist binds to the receptor but does not activate it, effectively blocking other signals.
The strength of the response is often proportional to the number of receptors occupied. Advanced
pharmacology focuses on the affinity and efficacy of these drugs at target sites. Understanding these
relationships is crucial for predicting therapeutic outcomes and potential side effects.
3. What is the primary reason for dosage adjustments in geriatric patients?
A. Increased gastric acidity
B. Rapid liver metabolism
C. Increased total body water
D. Decreased renal clearance
Ans: D
Rationale: As patients age, there is a natural decline in renal function and glomerular filtration rate. This
reduction leads to the slower excretion of drugs that are primarily cleared by the kidneys. If dosages are
,not adjusted, geriatric patients face a significantly higher risk of drug toxicity. Prescribers often use the
Cockcroft-Gault equation to estimate creatinine clearance in this population. It is also important to note
that physiological changes like increased body fat can alter distribution. Careful monitoring is the
cornerstone of safe prescribing for elderly individuals with multiple comorbidities.
4. Which drug class is most commonly associated with a dry, non-productive cough as a side
effect?
A. ACE inhibitors
C. Beta-blockers
B. Calcium channel blockers
D. Statins
Ans: A
Rationale: ACE inhibitors prevent the conversion of angiotensin I to angiotensin II to lower blood
pressure. A common side effect is a persistent dry cough caused by the accumulation of bradykinin in the
lungs. This cough can be bothersome enough to lead to patient non-compliance with the therapy. If the
cough persists, many providers switch the patient to an Angiotensin Receptor Blocker (ARB). ARBs
provide similar cardiovascular benefits without interfering with the breakdown of inflammatory
mediators. Recognizing this class-specific adverse effect is a key competency for advanced practice
nurses.
, 5. When prescribing for a pregnant patient, which FDA category previously indicated that
human fetal risk has been demonstrated?
A. Category A
B. Category B
C. Category X
D. Category C
Ans: C
Rationale: Category X was used for drugs where the risks of use in pregnant women clearly outweighed
any possible benefits. Studies in animals or humans showed evidence of fetal abnormalities or positive
evidence of fetal risk. Although the FDA has moved toward the Pregnancy and Lactation Labeling Rule
(PLLR), these categories are still widely referenced. Prescribers must evaluate the risk-to-benefit ratio for
every medication used during gestation. Safety is paramount because many substances cross the
placental barrier and affect fetal development. Accurate documentation and patient education are
required for all prescriptions given to expectant mothers.
